The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
May. 12, 2020
Applicant:
Richard Louis Price, Suffern, NY (US);
Inventor:
Richard Louis Price, Suffern, NY (US);
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A23L 3/3553 (2006.01); C07F 9/117 (2006.01); A61K 31/4168 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 9/00 (2006.01); A61K 31/047 (2006.01); A61K 45/06 (2006.01); A61J 1/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/395 (2013.01); A23L 3/3553 (2013.01); A61J 1/00 (2013.01); A61K 9/0004 (2013.01); A61K 31/047 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/4168 (2013.01); A61K 45/06 (2013.01); C07F 9/117 (2013.01); A61K 9/0087 (2013.01); A61K 2039/545 (2013.01);
Abstract
Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.